In vitro and in vivo evaluation of etoposide - silk wafers for neuroblastoma treatment.
J Control Release. 2018 Jul 03;285:162-171
Authors: Yavuz B, Zeki J, Coburn JM, Ikegaki N, Levitin D, Kaplan DL, Chiu B
Abstract High-risk neuroblastoma requires surgical resection and multi-drug chemotherapy. This study aimed to develop an extended release, implantable and degradable delivery system for etoposide, commonly used for neuroblastoma treatment.